These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15701279)
1. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279 [TBL] [Abstract][Full Text] [Related]
2. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 22 in human ependymomas. Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983 [TBL] [Abstract][Full Text] [Related]
6. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631 [TBL] [Abstract][Full Text] [Related]
7. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662 [TBL] [Abstract][Full Text] [Related]
8. Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154 [TBL] [Abstract][Full Text] [Related]
9. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Weremowicz S; Kupsky WJ; Morton CC; Fletcher JA Cancer Genet Cytogenet; 1992 Jul; 61(2):193-6. PubMed ID: 1638502 [TBL] [Abstract][Full Text] [Related]
15. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457 [TBL] [Abstract][Full Text] [Related]
16. Immune gene and cell enrichment is associated with a good prognosis in ependymoma. Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695 [TBL] [Abstract][Full Text] [Related]
17. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018 [TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas. Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary study on the gene expression profiles of ependymomas with cDNA array]. Jiang RC; Pu PY; Shen CH; Jiao BH; Yu SZ; Kang CS; Wang CY; Wang GX Zhonghua Wai Ke Za Zhi; 2003 Oct; 41(10):770-2. PubMed ID: 14766053 [TBL] [Abstract][Full Text] [Related]
20. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]